Equillium (EQ) Interest & Investment Income (2018 - 2026)
Equillium (EQ) posted quarterly Interest & Investment Income of $309000.0 for Q1 2026, up 78.61% year-over-year from $173000.0 in Q1 2025, and up 31.49% quarter-over-quarter from $235000.0 in Q3 2025.
Powered by 
Analysis
Equillium (EQ) Interest & Investment Income (2018 - 2026) Analysis & Trends
Equillium (EQ) has reported Interest & Investment Income for 9 consecutive years, with $309000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 78.61% year-over-year to $309000.0; the TTM figure through Mar 2026 stood at $666000.0 (up 272.07% YoY), while the FY2025 annual figure was -$3000.0, up 80.0% from the prior year.
- Interest & Investment Income improved to $309000.0 in Q1 2026 per EQ's latest filing, from $235000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $309000.0 in Q1 2026 and bottomed at -$257000.0 in Q4 2022.
- Historically, Interest & Investment Income has averaged $35687.5 across 5 years, with a median of $20000.0 in 2023.
- On a YoY basis, Interest & Investment Income climbed as much as 4433.33% in 2022 and fell as far as 2670.0% in 2022.
- Equillium's Interest & Investment Income stood at -$257000.0 in 2022, then surged by 111.67% to $30000.0 in 2023, then slumped by 130.0% to -$9000.0 in 2024, then surged by 2711.11% to $235000.0 in 2025, then soared by 31.49% to $309000.0 in 2026.
- Business Quant data shows EQ's Interest & Investment Income at $309000.0 in Q1 2026, $235000.0 in Q3 2025, and $122000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Equillium | 249.33 Mn | 249.33 Mn | - | 509,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 509,000.00 |
| Mar 31, 2026 | 309,000.00 |
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Dec 31, 2024 | 239,000.00 |
| Sep 30, 2024 | 331,000.00 |
| Jun 30, 2024 | 371,000.00 |
| Mar 31, 2024 | 439,000.00 |
| Dec 31, 2023 | 517,000.00 |
| Sep 30, 2023 | 551,000.00 |
| Jun 30, 2023 | 627,000.00 |
| Mar 31, 2023 | 639,000.00 |
| Dec 31, 2022 | 201,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | -180,000.00 |
| Dec 31, 2021 | -106,000.00 |
| Sep 30, 2021 | 8,000.00 |